Anupam Rasayan India Limited has informed the Exchange about Rumour Verification - Regulation 30(11)
ANURAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anupam Rasayan India Ltd has issued a clarification under SEBI LODR Regulation 30(11) in response to a media report claiming the company was planning to acquire a stake in Bliss GVS Pharma Ltd. The company has stated that there is no such material event or information that warrants disclosure under Regulation 30. It has declined to comment on the speculation and affirmed that it continues to comply with all relevant disclosure norms. The filing was made to both BSE and NSE on February 13, 2026.
This is a rumour denial and may temporarily calm investor sentiment if the market had reacted to the acquisition speculation. However, the company's refusal to comment fully could leave some uncertainty, and investors should watch for any further official announcements regarding Bliss GVS Pharma.